HCQ's emergency use revocation by US may not hit India's exports

This is because while emergency-use authorisation for treating Covid-19 was a recent move, the drug has been used since years for rheumatoid arthritis and lupus

Even as the US government revoked emergency use of hydroxychloroquine (HCQ) for treating coronavirus (Covid-19) patients, smaller players in India do not see much impact on export of the drug.
 

This is because while the emergency authorisation for treating Covid was a recent move, the drug has been used since years for rheumatoid arthritis (RA) and autoimmune lupus.
 

“Revocation of the emergency use approval means that the drug can be reused in future when approved after a clinical study. However, the decades-old drug is used in RA and lupus which still continues. Use of HCQ for treating Covid has been